期刊
CRITICAL REVIEWS IN MICROBIOLOGY
卷 47, 期 3, 页码 275-289出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/1040841X.2021.1876632
关键词
Antimicrobial resistance; fungal susceptibility; neglected diseases; antifungal drugs
类别
资金
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/04592-0, 2015/09727-6]
The global scenario of antimicrobial resistance is concerning, with slow progress in the development of new drugs. Difficulties in finding new targets for therapy, high development costs, and the mismatch between drug introduction and microbial adaptation are constraints in drug discovery.
The global scenario of antimicrobial resistance is alarming, and the development of new drugs has not appeared to make substantial progress. The constraints on drug discovery are due to difficulties in finding new targets for therapy, the high cost of development, and the mismatch between the time of drug introduction in a clinic and microorganism adaptation to a drug. Policies to address neglected diseases miss the broad spectrum of mycosis. Society is not aware of the actual threat represented by fungi to human health, food security, and biodiversity. The evidence discussed here is critical for warning governments to establish effective surveillance policies for fungi.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据